As a consulting firm focused on the consumer products and life sciences industries, we are excited to provide our expert ...

In addition to working with some of the most innovative companies in the life sciences industry, one of the greatest ...

The FDA's Plan to Transform & Evolve Through Data

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s ...

Late in 2015, a global pharmaceutical company was, for the first time, beginning to suffer from an increasingly competitive landscape ...

A leading global pharmaceutical company needed to rethink how it approached the ongoing digital revolution. With over $50 billion in annual ...

Life sciences companies will need to reevaluate their marketing approach as off-label and direct-to-customer (DTC) marketing continue to draw attention. In recent ...

As large pharmaceutical companies increase their focus on orphan and specialty drugs, they are also seeking ways to reduce operating expenses and ...

In a letter this week to its suppliers, McKesson—the largest pharmaceutical distributor in the United States—addressed their expectations relating to ...

While increased healthcare spend will likely lead to higher revenues for manufacturers, life sciences companies will focus heavily on addressing ...

Launching a new, undifferentiated drug in a mature and highly regulated market can be challenging—even for an established organization. Facing the ...

The leadership team of a multinational healthcare company was dissatisfied with the organization’s ability to realize true value from its large scale. ...